{"public_id":"cl_3b9b4df8adb770c085798c875aca9877","status":"active","superseded_by_public_id":null,"corpus_id":35107128,"text":"Minor differences were observed between the two schedules in the percentage of individuals with titers against poliovirus types 1 and 3 during the study.","confidence":0.86,"paper":{"corpus_id":35107128,"title":"Trivalent oral poliovirus vaccine: a comparison of two infant immunization schedules.","url":"https://sah.borca.ai/papers/35107128"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.86,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_41a1d8d8fa54ea71302cfb077e9aedfe","name":"poliovirus types 1 and 3","description":"Two poliovirus serotypes evaluated for antibody response in the immunization comparison.","types":["viral serotypes"],"url":"https://sah.borca.ai/concepts/co_41a1d8d8fa54ea71302cfb077e9aedfe"},{"public_id":"co_7b88dd351a4f276ed9b9f7475d242403","name":"3-dose primary series","description":"An infant immunization schedule consisting of three primary doses.","types":["immunization schedule"],"url":"https://sah.borca.ai/concepts/co_7b88dd351a4f276ed9b9f7475d242403"},{"public_id":"co_88e5cb61983a46e8a922039a75b27b64","name":"4-dose series","description":"An infant immunization schedule consisting of four primary doses.","types":["immunization schedule"],"url":"https://sah.borca.ai/concepts/co_88e5cb61983a46e8a922039a75b27b64"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_3b9b4df8adb770c085798c875aca9877"}